Age related treatment effect in type II Spinal Muscular Atrophy pediatric patients treated with nusinersen.
Coratti G, Pane M, Lucibello S, Pera MC, Pasternak A, Montes J, Sansone VA, Duong T, Dunaway Young S, Messina S, D'Amico A, Civitello M, Glanzman AM, Bruno C, Salmin F, Tacchetti P, Carnicella S, Sframeli M, Antonaci L, Frongia AL, De Vivo DC, Darras BT, Day J, Bertini E, Muntoni F, Finkel R, Mercuri E; iSMAC group.
Coratti G, et al. Among authors: montes j.
Neuromuscul Disord. 2021 Jul;31(7):596-602. doi: 10.1016/j.nmd.2021.03.012. Epub 2021 Apr 2.
Neuromuscul Disord. 2021.
PMID: 34099377